Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Amed Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Amed Ventures

Amed Ventures

Operating

AMED Ventures: A San Francisco-based venture capital firm, investing in impactful MedTech innovations.

Location
San Francisco, CA, US
Founded
2018
Firm
Compare
Portfolio
Employees
News
Website

AMED Ventures is a San Francisco-based venture capital firm specializing in MedTech innovations. The firm focuses on funding exceptional entrepreneurs and impactful medical technology startups, typically investing in Series A through Series E rounds. Their investment strategy aims to support companies that can make significant advancements in healthcare, leveraging their extensive experience in investment, business development, and operational management.

Notable portfolio companies include Adona Medical, Akura Medical, Atia Vision, and Imperative Care, among others. The firm prides itself on providing value-added services beyond capital, aiding entrepreneurs and portfolio companies with strategic guidance and operational support. Key partners at AMED Ventures bring a wealth of experience from both large public corporations and startups, ensuring a robust support system for their investments.

Amed Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments19
Current Portfolio Count12
Total Portfolio Exits0

Top Investment Stages

Series B6 (33.3%)
Series C4 (22.2%)
Series A3 (16.7%)
Series D3 (16.7%)
Series Unknown2 (11.1%)

Stage Mix

Series B 33%Series C 22%Series A 17%Series D 17%Series Unknown 11%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Supira Medical logo

Supira Medical

Akura Medical logo

Akura Medical

Instylla logo

Instylla

Sealonix logo

Sealonix

Tioga Cardiovascular logo

Tioga Cardiovascular

Rejoni logo

Rejoni

Ostial logo

Ostial

Atia Vision logo

Atia Vision

Adona Medical logo

Adona Medical

Tulavi Therapeutics logo

Tulavi Therapeutics

Imperative Care logo

Imperative Care

Neurolutions logo

Neurolutions

Amed Ventures - Similar Investment Firms

MedVenture Associates logo

MedVenture Associates

Ambit Health Ventures logo

Ambit Health Ventures

Almeda Ventures logo

Almeda Ventures

almedaventures.com

Amity Ventures logo

Amity Ventures

amity.vc

MedMountain Ventures logo

MedMountain Ventures

mmv.vc

Amkey Ventures logo

Amkey Ventures

MedVenture Health logo

MedVenture Health

MedScience Ventures logo

MedScience Ventures

Accuitive Medical Ventures logo

Accuitive Medical Ventures

Asset Management Ventures logo

Asset Management Ventures

assetman.com

Providence Ventures logo

Providence Ventures

BioMed Ventures logo

BioMed Ventures

5AM Ventures logo

5AM Ventures

5amventures.com

Aditum Bio logo

Aditum Bio

aditumbio.com

Particular Ventures logo

Particular Ventures

Amed Ventures - Classification

NAICS
  • 520000Finance and Insurance
SIC
  • 6000Depository Institutions
Show 7 more industry codes
NAICS
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end